NasdaqGS - Delayed Quote USD
Natera, Inc. (NTRA)
154.48
+5.92
+(3.98%)
At close: April 24 at 4:00:00 PM EDT
156.00
+1.52
+(0.98%)
Pre-Market: 4:27:04 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 833,529 | 58 |
| Sales | 867,257 | 65 |
| Net Shares Purchased (Sold) | -33,728 | 123 |
| Total Insider Shares Held | 4.64M | -- |
| % Net Shares Purchased (Sold) | -0.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Sale at price 145.54 - 146.07 per share. | Direct | 242,190 | Apr 21, 2025 |
| RABINOWITZ DANIEL A Officer | Sale at price 145.54 - 146.16 per share. | Direct | 68,408 | Apr 21, 2025 |
| FESKO JOHN President | Sale at price 145.54 - 146.10 per share. | Direct | 49,922 | Apr 21, 2025 |
| MOSHKEVICH SOLOMON Officer | Sale at price 145.54 - 146.85 per share. | Direct | 43,085 | Apr 21, 2025 |
| SHEENA JONATHAN Director | Sale at price 145.54 - 146.16 per share. | Direct | 12,517 | Apr 21, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Sale at price 145.54 - 146.16 per share. | Direct | 88,784 | Apr 21, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | -- | Direct | -- | Apr 17, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | -- | Direct | -- | Apr 17, 2025 |
| RABINOWITZ DANIEL A Officer | -- | Direct | -- | Apr 17, 2025 |
| SHEENA JONATHAN Director | -- | Direct | -- | Apr 17, 2025 |
| SHEENA JONATHAN Director | Sale at price 132.04 - 141.28 per share. | Indirect | 826,327 | Apr 4, 2025 |
| MARCUS GAIL BOXER Director | Sale at price 139.33 - 142.82 per share. | Direct | 563,100 | Apr 1, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Sale at price 138.41 - 142.28 per share. | Direct | 3,556,948 | Apr 1, 2025 |
| MOSHKEVICH SOLOMON Officer | Sale at price 139.78 - 141.90 per share. | Direct | 421,428 | Apr 1, 2025 |
| MARCUS GAIL BOXER Director | Conversion of Exercise of derivative security at price 7.86 - 24.42 per share. | Direct | 78,967 | Apr 1, 2025 |
| RABINOWITZ DANIEL A Officer | Sale at price 138.39 - 138.41 per share. | Direct | 194,327 | Mar 31, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Sale at price 138.36 - 138.41 per share. | Direct | 354,603 | Mar 31, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | -- | Direct | -- | Mar 28, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | -- | Direct | -- | Mar 28, 2025 |
| RABINOWITZ DANIEL A Officer | -- | Direct | -- | Mar 28, 2025 |
| BERTAGNOLLI MONICA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2025 |
| SHEENA JONATHAN Director | Sale at price 145.09 - 146.81 per share. | Indirect | 856,410 | Mar 18, 2025 |
| RABINOWITZ MATTHEW Officer and Director | Sale at price 146.03 - 149.58 per share. | Direct | 164,584 | Mar 17, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Sale at price 146.03 per share. | Direct | 978,678 | Mar 17, 2025 |
| RABINOWITZ DANIEL A Officer | Sale at price 146.03 - 149.74 per share. | Direct | 135,521 | Mar 17, 2025 |
| FESKO JOHN President | Sale at price 146.03 - 149.58 per share. | Direct | 116,099 | Mar 17, 2025 |
| MOSHKEVICH SOLOMON Officer | Sale at price 146.03 - 149.74 per share. | Direct | 149,836 | Mar 17, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Sale at price 146.03 - 149.58 per share. | Direct | 115,661 | Mar 17, 2025 |
| RABINOWITZ MATTHEW Officer and Director | Sale at price 145.37 - 149.00 per share. | Direct | 7,385,249 | Mar 14, 2025 |
| MARCUS GAIL BOXER Director | Sale at price 145.86 - 149.27 per share. | Direct | 590,773 | Mar 12, 2025 |
| MARCUS GAIL BOXER Director | Conversion of Exercise of derivative security at price 7.86 per share. | Direct | 31,440 | Mar 12, 2025 |
| RABINOWITZ MATTHEW Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 12, 2025 |
| SHEENA JONATHAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 12, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 12, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 12, 2025 |
| RABINOWITZ DANIEL A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 12, 2025 |
| FESKO JOHN President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 12, 2025 |
| MOSHKEVICH SOLOMON Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 12, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Sale at price 141.91 - 145.42 per share. | Direct | 12,515,006 | Mar 5, 2025 |
| MOSHKEVICH SOLOMON Officer | Sale at price 142.08 - 144.97 per share. | Direct | 859,734 | Mar 5, 2025 |
| SHEENA JONATHAN Director | Sale at price 155.66 - 162.64 per share. | Indirect | 914,873 | Feb 26, 2025 |
| FESKO JOHN President | Sale at price 177.77 per share. | Direct | 117,862 | Feb 6, 2025 |
| MOSHKEVICH SOLOMON Officer | Sale at price 177.77 per share. | Direct | 290,121 | Feb 6, 2025 |
| FESKO JOHN President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 5, 2025 |
| MOSHKEVICH SOLOMON Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 5, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Sale at price 173.05 - 178.19 per share. | Direct | 7,763,862 | Feb 3, 2025 |
| SHEENA JONATHAN Director | Sale at price 165.87 - 176.60 per share. | Direct | 203,613 | Jan 31, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Sale at price 165.87 - 176.60 per share. | Direct | 1,052,112 | Jan 31, 2025 |
| ROSENMAN HERMAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| HEALY JAMES I Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
Related Tickers
GH Guardant Health, Inc.
47.41
+3.88%
EXAS Exact Sciences Corporation
45.60
+3.42%
VCYT Veracyte, Inc.
32.14
+2.15%
WGS GeneDx Holdings Corp.
109.39
+3.50%
PSNL Personalis, Inc.
3.8300
+4.08%
GRAL GRAIL, Inc.
37.69
+11.64%
ILMN Illumina, Inc.
77.61
+1.78%
TWST Twist Bioscience Corporation
40.17
+6.78%
DGX Quest Diagnostics Incorporated
175.87
+1.33%
LH Labcorp Holdings Inc.
228.58
+1.98%